Previous Seminars
- March 06, 2023
- Reading seminar with Shiri Mermelstein & Mathias Dewatripont
“Orphan drugs, clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement”
(H. G Eichler, M. Kossmeier, M. Zeitlinger, & B. Schwarzer-Daum)Presentation of paper: Shiri Mermelstein (I3h)
Discussion: Mathias Dewatripont (I3h and ECARES)Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by March 1: nfriedlaender@i3health.eu)
or Online via Zoom: Register here
- February 13, 2023
- Reading seminar by Michel Goldman
Michel Goldman,
Founding President, I3h Institute, ULBMember of the Advisory Forum to the European Health Emergency Preparedness and Response Authority (HERA)
Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by February 9: nfriedlaender@i3health.eu)
or Online via Zoom: Register here
- December 19, 2022
- Reading seminar by Bram De Rock
Bram De Rock, Vice-dean of research at SBS-EM, Director of ECARES and Full professor at ULB and KU Leuven
Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by December 14: nfriedlaender@i3health.eu)
- December 15, 2022
- Reading seminar by James Robinson
James Robinson, Professor of Health Economics in the School of Public Health at the University of California, Berkeley
Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by December 12: nfriedlaender@i3health.eu)
- November 21, 2022
- Reading Seminar: "Market Size and Innovation in Antibiotics" by Ilaria Natali
Ilaria Natali, Post-Doc, University of Toulouse and PhD, ECARES (ULB)
Join us onsite on ULB Campus Solbosch – Building H, Room H3.366 (please confirm your attendance to Naomi Friedlaender by November 16: nfriedlaender@i3health.eu)
- October 03, 2022
- Mums Go Online: Is the Internet Changing the Demand for Healthcare?
Mattia Nardotto, Solvay Brussels School of Economics & Management (ULB)
Online: Register via Zoom: here
- May 16, 2022
- Connected Health
Vincent Mabillard, PhD, Assistant Professor at the Solvay Brussels School of Economics & Management (ULB)
Jan Mattijs, Professor at the Solvay Brussels School of Economics & Management (ULB)
Online: Register via Zoom: here
- May 02, 2022
- The Morality of Markets
Mathias Dewatripont, Co-director of the I3h Institute and Professor at the Solvay Brussels School of Management and Economics
The presentation will be based on the paper accessible here and will emphasize as applications the opioid crisis and the legal status of nursing homes.
- March 28, 2022
- The mRNA Corona Vaccine Story
Reinhilde Veugelers, Senior Fellow at Bruegel and PIIE and Full Professor at KULeuven
Please find the full presentation here.
- March 14, 2022
- The impact of COVID-19 Certificates: Complementary approaches
Miquel OLIU-BARTON Université Paris‐Dauphine (France) and Bruegel (Belgium)
Bary S.R. PRADELSKI Centre National de la Recherche Scientifique (France) and Oxford‐Man Institute of Quantitative Finance (University of Oxford) (UK)
Abel FRANCOIS Université de Lille (LEM) and Centre de Données Socio-Politiques (CDSP), Sciences Po (France)
Olivier GERGAUD Kedge Business School and LIEPP, Sciences Po (France)
Abdul NOURY New York University (Abu Dhabi)Online: Register via Zoom: here
- December 13, 2021
- Countering the Tragedy of the Health Care Commons by Exnovation. Bringing Unexpected Problems and Solutions into View
WILLEMINE WILLEMS Postdoctoral Researcher and Lecturer at Athena Institute, Vrije Universiteit Amsterdam
Online: Register via Zoom: here
- December 06, 2021
- «Safety first» in healthcare? Really?
DENIS HERBAUX Solvay Brussels School of Economics and Management ; PAQS asbl
Online: Register via Zoom: here
- November 15, 2021
- Stopping rule and sex selective abortion: new measures and world evidence
GUILHEM CASSAN Associate Professor, University of Namur
- Online: Register via Zoom: here
- October 18, 2021
- Vaccination strategies in the midst of a pandemic
MATHIAS DEWATRIPONT Co-Director, I3h Institute (ULB)
- Online: Register via Zoom: here
- On-site: ULB Campus Solbosch (Av. Paul Héger 6, Building H, room H.3.366)
- May 31, 2021
- Innovation Diffusion and Physician Networks: lessons from keyhole surgery in the UK
MARISA MIRALDO Associate Professor in Health Economics, Imperial College London
- May 17, 2021
- The global challenge of vaccine access: the CEPI initiative
LUC DEBRUYNE Strategic Advisor at the Coalition for Epidemic Preparedness Innovations (CEPI); Former President of GSK Global Vaccines
- April 19, 2021
- Economists' contributions to understanding the Covid pandemic
CHARLES WYPLOSZ Emeritus Professor at the Graduate Institute in Geneva, Editor of Covid Economics at the Centre for Economic Policy Research
- March 08, 2021
- What pharma ownership means for its optimal regulation
ANTONIO ESTACHE Professor of Economics, Université Libre de Bruxelles, Belgium; Research Fellow, European Center for Advanced Research in Economics and Statistics (ECARES), Brussels
- February 22, 2021
- Early-Childhood Exposure to Civil War and Teenage Cognitive Development
PHILIP VERWIMP Member of the ECARES, Solvay Brussels School of Economics and Management, I3h Institute; Co-director, Households in Conflict Network
- February 08, 2021
- Health, economics and wellbeing in pandemic times
PHILIPPE BEUTELS Scientific director of the Centre for Health Economics Research & Modeling Infectious Diseases (CHERMID) of the Vaccine & Infectious Disease Institute (University of Antwerp)
- January 25, 2021
- Control of antimicrobial resistance in low- and middle-income countries
OLIVIER VANDENBERG School of Public Health, Université Libre de Bruxelles (ULB); Division of Infection & Immunity, UCL, London, UK
- January 18, 2021
- COVID-19 mRNA vaccines: What do we know about their safety and how do we mitigate the risks?
JEAN-MICHEL DOGNÉ Head of the Department of Pharmacy at the University of Namur, Member of the EMA’s Pharmacovigilance Risk Assessment Committee and WHO’s Global Advisory Committee on Vaccine Safety
- December 14, 2020
- Mental Models and Learning: The Case of Base-Rate Neglect
SEVGI YUKSEL Assistant Professor of Economics at University of California Santa Barbara
REGISTRATION
- December 07, 2020
- Public money for clinical research in oncology: a necessity
LYDIE MEHEUS Managing Director, Anticancer Fund
REGISTRATION
- November 23, 2020
- Who should get it first? Public preferences for distributing a COVID-19 vaccine
SANDY TUBEUF Professor of Health Economics, UCLouvain
REGISTRATION
- November 16, 2020
- Entry decisions and asymmetric competition between non-profit and for-profit homes in the long-term care market
Iris Kesternich Professor of Behavioral Economics, KU Leuven
- October 26, 2020
- Real-time epidemiology to monitor COVID-19: from data-analysis to communication and decision-making
Marius Gilbert Head of the Spatial Epidemiology Lab, ULB Research director at FNRS-FRSS
- October 12, 2020
- La saga des herbes chinoises, une lecon de sante publique
Jean-Louis Vanherweghem Professor Emeritus of the ULB, Member of the Royal Academy of Medicine
- October 12, 2020
- La saga des herbes chinoises, une lecon de sante publique
Marius Gilbert FNRS Research director at the ULB Head of the spatial epidemiology Lab Member of the former GEES
- October 05, 2020
- Modelling the SARS-CoV-2 pandemic - focus on Belgium
Niel Hens Professor at UAntwerpen and UHasselt, Member of the former Group of Experts for the Exit Strategy (GEES)s
- September 28, 2020
- Innovative medicines: reconciling public health and business
Ri De Ridder former director-general at the National Institute for Health and Disability Insurance (Inami/Riziv), i.a. managing the medicines reimbursement process, and current president on the board of directors for Doctors of the World Belgium
- February 24, 2020
- Development of a priority-setting algorithm for vaccines: a discrete choice experiment
Jeroen Luyten Associate Professor of Health Economics at the Leuven Institute for Healthcare Policy and a visiting fellow at the London School of Economics
- February 03, 2020
- Augmented Medicine - The way Artificial Intelligence is reshaping clinical practice
Giovanni Briganti Associate Lecturer of Medical Technology (AI & Health) at ULB and Lecturer of Physiology at the ES Santé School of Health
- January 20, 2020
- The economic cost of air pollution: evidence from Europe
Antoine Dechezleprêtre Senior Economist at OECD
- December 09, 2019
- “Ethics, markets and organizations” (joint work with Jean Tirole)
Mathias Dewatripont Former Executive Director of the National Bank of Belgium and Dean of the Solvay Brussels School of Economics and Management
- November 25, 2019
- A new year, a new you? A two-selves model of within-individual variation in food purchases
Bram De Rock Professor in Mathematical Economics at ULB and KU Leuven; Director of ECARES
- November 04, 2019
- The importance of social network in health, health care and in health policies
Vincent Lorant Professor at Faculty of Public Health, UCL
- October 21, 2019
- The economic cost of air pollution: Evidence from Europe
Antoine Dechezleprêtre Senior Economist at OECD
- September 30, 2019
- Vaccines hesitancy
Marie Neunez Research fellow at Institute for Interdisciplinary Innovation in healthcare (I3h)
- June 03, 2019
- Effects of physician-industry interactions on treatments: the case of heart attacks
Sofia Amaral-Garcia Postdoc Researcher at Hasselt University, in the research group Economics and Public Policy
- May 16, 2019 - June 03, 2019
- Opioid analgesics consumption in France
Ilaria Natali Teaching Assistant for Advanced Industrial Organization, ULB
- April 29, 2019
- Market access of pharmaceutical innovation: international R&D, high prices and national competent authorities
Philippe Van Wilder Professor in health economics and HTA at Ecole de Santé Publique, ULB
- February 18, 2019
- Subsidized Health Insurance and Healthcare Utilization: new evidence from a large-scale field experiment
Raf Van Gestel Assistant Professor, Erasmus School of Economics & Erasmus School of Health Policy and Management
- January 21, 2019
- Therapeutic drug monitoring of biologics: where to start, where to end?
Lynda Grine Doctor-assistant at Ghent University and Research Associate at the Dermatology Department of Ghent University Hospital
- December 10, 2018
- Scientific, regulatory, and economic challenges facing the implementation of phage therapy and the Belgian model.
Bob Blasdel Research Director for Vesale Pharma
- November 30, 2018
- The case of a multi-drug resistant infection
- November 26, 2018
- Precision oncology: how to structure the continuum of clinical research into healthcare for rationale access to anti-cancer treatment
Denis Lacombe Director General of the European Organisation for Research and Treatment of Cancer
- November 12, 2018
- Market definition in the pharmaceutical industry: a case of drugs hopping antitrust markets
Georges Siotis Associate Professor at the Economics Department of Universidad Carlos III de Madrid and CEPR Research Fellow
- October 29, 2018
- Towards new partnerships in the healthcare sector
Wim Van Haverbeke Professor of Innovation Management & Strategy at the Hasselt University
- October 08, 2018
- Vaccines: how to value them, how to price them?
Michel Dewilde MDWConsultant, former Senior Vice President R&D, Sanofi Pasteur
- October 01, 2018
- Measuring mortality in conflicts and disasters: why does it matter?
Debarati Guha Director of the Centre for Research on the Epidemiology of Disasters (CRED) and Professor at the School of Public Health (UCL)
- June 04, 2018
- Public funding and influential health research: Evidence from the US and the UK
Charitini Stavropoulou Senior Lecturer in Health Management at the School of Health Sciences (City University of London)
- May 28, 2018
- Endogenous childlessness and stages of development
Paula E. Gobbi Member of ECARES (ULB) and CEPR
- May 07, 2018
- Translational hepatology: scientific, economic and financial challenges
Etienne Sokal Professor at UCLouvain, Hepatologist at Cliniques Universitaires Saint Luc and Founder of Promethera Biosciences
- April 23, 2018
- Novel approaches to pricing and reimbursement for innovative medicines
Lieven Annemans Professor of Health Economics at the Medical Faculty of Ghent University
- April 09, 2018
- Value assessment and reimbursement: the (special?) case of orphan drugs
Steven Simoens Professor at the Faculty of Pharmaceutical Sciences (KU Leuven)
- March 19, 2018
- Subgroup and post-hoc analyses in clinical trials: the truth lies in the eye of the beholder
Bruno Flamion MD, PhD, Professor of Clinical Pharmacology (UNamur) and VP Head Strategic Development (Idorsia Pharmaceuticals)
- March 05, 2018
- Are ideas getting harder to find?
Øyvind Aas Post-doctoral researcher at ECARES, ULB
- February 26, 2018
- Economic value of vaccines for the developing world: different perspectives
Bill Hausdorff Senior Lecturer at Faculté de Médecine ULB, Independent Consultant
- February 12, 2018
- Awareness and AIDS: A Political Economy Perspective
by Gani Aldashev Professor at ULB
- January 29, 2018
- The opioid crisis: what went wrong? Crossing medical and economic perspectives.
Maurice Sosnowski MD, professor at ULB and Mathias Dewatripont PhD, Co-director of I3h, professor of Economics at ULB
- January 15, 2018
- The Unexpected Consequences of Asymmetric Competition: An Application to the Pharmaceutical Industry.
Micael Castanheira PhD, Director for Research at FRS-FNRS
- December 11, 2017
- Redefining health policy for effective coverage: Where do we stand in Tuberculosis control?
Samia Laokri PhD, Assistant Professor at ULB
- November 27, 2017
- Do regulatory agencies hamper therapeutic innovation?
Mathias Dewatripont PhD, Co-director of I3h, professor of Economics at ULB
- November 13, 2017
- The changing face of clinical trials and their impact on industrial R&D
Michel Goldman MD, PhD, Co-director I3h , professor at ULB and Chief Editor of ‘Frontiers in Medicine’
- October 30, 2017
- Intellectual property policies in early-phase research in public-private partnerships
Hilde Stevens PhD, Baillet Latour Chair in Translational Medicine, Associate Professor (ULB)
